Literature DB >> 33642790

Advanced molecular characterization of enteropathogenic Escherichia coli isolated from diarrheic camel neonates in Egypt.

Momtaz A Shahein1, Amany N Dapgh1, Essam Kamel1, Samah F Ali1, Eman A Khairy2, Hussein A Abuelhag2, Ashraf S Hakim2.   

Abstract

BACKGROUND AND AIM: Camels are important livestock in Egypt on cultural and economic bases, but studies of etiological agents of camelid diseases are limited. The enteropathogen Escherichia coli is a cause of broad spectrum gastrointestinal infections among humans and animals, especially in developing countries. Severe infections can lead to death. The current study aimed to identify pathogenic E. coli strains that cause diarrhea in camel calves and characterize their virulence and drug resistance at a molecular level.
MATERIALS AND METHODS: Seventy fecal samples were collected from diarrheic neonatal camel calves in Giza Governorate during 2018-2019. Samples were cultured on a selective medium for E. coli, and positive colonies were confirmed biochemically, serotyped, and tested for antibiotic susceptibility. E. coli isolates were further confirmed through detection of the housekeeping gene, yaiO, and examined for the presence of virulence genes; traT and fimH and for genes responsible for antibiotic resistance, ampC, aadB, and mphA. The isolates in the important isolated serotype, E. coli O26, were examined for toxigenic genes and sequenced.
RESULTS: The bacteriological and biochemical examination identified 12 E. coli isolates from 70 fecal samples (17.1%). Serotyping of these isolates showed four types: O26, four isolates, 33.3%; O103, O111, three isolates each, 25%; and O45, two isolates, 16.7%. The isolates showed resistance to vancomycin (75%) and ampicillin (66.6%), but were highly susceptible to ciprofloxacin, norfloxacin, and tetracycline (100%). The structural gene, yaiO (115 bp), was amplified from all 12 E. coli isolates and traT and fimH genes were amplified from 10 and 8 isolates, respectively. Antibiotic resistance genes, ampC, mphA, and aadB, were harbored in 9 (75%), 8 (66.6%), and 5 (41.7%), respectively. Seven isolates (58.3%) were MDR. Real-time-polymerase chain reaction of the O26 isolates identified one isolate harboring vt1, two with vt2, and one isolate with neither gene. Sequencing of the isolates revealed similarities to E. coli O157 strains.
CONCLUSION: Camels and other livestock suffer various diseases, including diarrhea often caused by microbial pathogens. Enteropathogenic E. coli serotypes were isolated from diarrheic neonatal camel calves. These isolates exhibited virulence and multiple drug resistance genes. Copyright: © Shahein, et al.

Entities:  

Keywords:  camel; multidrug-resistant Escherichia coli; real-time polymerase chain reaction; sequencing; virulence

Year:  2021        PMID: 33642790      PMCID: PMC7896916          DOI: 10.14202/vetworld.2021.85-91

Source DB:  PubMed          Journal:  Vet World        ISSN: 0972-8988


  32 in total

1.  Pathotyping of diarrhoeagenic cattle Escherichia coli strains isolated in the Province of Tehran, Iran.

Authors:  Hamid Staji; Pietro Badagliacca; Taghi Zahraei Salehi; Federica Lopes; Mariangela Iorio; Alfreda Tonelli; Luc Masson
Journal:  Vet Ital       Date:  2017-12-29       Impact factor: 1.101

2.  Tracking verocytotoxigenic Escherichia coli O157, O26, O111, O103 and O145 in Irish cattle.

Authors:  K M Thomas; M S McCann; M M Collery; A Logan; P Whyte; D A McDowell; G Duffy
Journal:  Int J Food Microbiol       Date:  2011-11-29       Impact factor: 5.277

3.  Analysis of Bacterial Diversity in Relation to the Presence of the Top 7 Shiga Toxin-Producing Escherichia coli throughout Australian Beef Abattoirs.

Authors:  Sanga Kang; Joshua T Ravensdale; Ranil Coorey; Gary A Dykes; Robert S Barlow
Journal:  J Food Prot       Date:  2020-10-01       Impact factor: 2.077

4.  Zoonotic potential of atypical enteropathogenic Escherichia coli (aEPEC) isolated from puppies with diarrhoea in Brazil.

Authors:  Lavicie R Arais; André V Barbosa; João R C Andrade; Tânia A T Gomes; Marise D Asensi; Caio A M Aires; Aloysio M F Cerqueira
Journal:  Vet Microbiol       Date:  2018-10-30       Impact factor: 3.293

5.  Virulent gene profile and antibiotic susceptibility pattern of Shiga toxin-producing Escherichia coli (STEC) from cattle and camels in Maiduguri, North-Eastern Nigeria.

Authors:  Musa Sakuma Adamu; Iniobong Chukwuebuka Ikenna Ugochukwu; Sunday Idoko Idoko; Yakubu Adamu Kwabugge; Nafisatu Sa'ad Abubakar; James Ameh Ameh
Journal:  Trop Anim Health Prod       Date:  2018-03-21       Impact factor: 1.559

Review 6.  An overview of diarrheagenic Escherichia coli in Iran: A systematic review and meta-analysis.

Authors:  Hesam Alizade; Saeed Hosseini Teshnizi; Mohsen Azad; Saeed Shojae; Hamed Gouklani; Parivash Davoodian; Reza Ghanbarpour
Journal:  J Res Med Sci       Date:  2019-03-25       Impact factor: 1.852

Review 7.  Cellular and Molecular Adaptation of Arabian Camel to Heat Stress.

Authors:  Abdullah Hoter; Sandra Rizk; Hassan Y Naim
Journal:  Front Genet       Date:  2019-06-19       Impact factor: 4.599

8.  Shiga toxin-producing Escherichia coli (STEC) isolated from fecal samples of African dromedary camels.

Authors:  Melinda Baschera; Nicole Cernela; Marc J A Stevens; Anne Liljander; Jörg Jores; Victor Max Corman; Magdalena Nüesch-Inderbinen; Roger Stephan
Journal:  One Health       Date:  2019-03-07

9.  Genomic Characterization of Escherichia coli Isolates Belonging to a New Hybrid aEPEC/ExPEC Pathotype O153:H10-A-ST10 eae-beta1 Occurred in Meat, Poultry, Wildlife and Human Diarrheagenic Samples.

Authors:  Dafne Díaz-Jiménez; Isidro García-Meniño; Alexandra Herrera; Vanesa García; Ana María López-Beceiro; María Pilar Alonso; Jorge Blanco; Azucena Mora
Journal:  Antibiotics (Basel)       Date:  2020-04-17

10.  Occurrence, virulence genes, and antimicrobial profiles of Escherichia coli O157 isolated from ruminants slaughtered in Al Ain, United Arab Emirates.

Authors:  Dawood Al-Ajmi; Shafeeq Rahman; Sharmila Banu
Journal:  BMC Microbiol       Date:  2020-07-16       Impact factor: 3.605

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.